✌️more important points:
1. Make sure your colours are accessible - should be visible & have high contrast w.r.t medium.
2. Use colour-blind-friendly colour palette - Blue/red or blue/brown generally work.
For starters: colourbrewer2 is a great free tool to use.
@iamscicomm
Hope this clarifies the process behind early warning systems for variants. Omicron is a good example as discussed here. Thanks to colleagues at WHO technical advisory group for SARS CoV2 evolution @WHO@mvankerkhove@AshokaUniv@MarionKoopmans@Sci_Lipi
Check out a new study on Monocytes in Dengue infected children from India by our lab ICGEB-Emory Vaccine Center is available now in iScience. @Deepti_3191@prashant2bajpai@EmoryVaccineCtr@ICGEB congratulations to whole team 🎉👌🏻
https://t.co/N2CJYG96f8
And came the difficult moment of bidding farewell to Dr. Anurag Agrawal.
"He is not leaving IGIB, but carrying the culture of IGIB forward." -Prof. Samir Brahamachari
Actively looking for 1-2 research intern student(s) to work in the field of human mAbs isolation for a period of 3-6 months. Interested ones can send his/her CV.
Please RT.
Catch me in conversation with Vivek Sharma, Managing Director, Infrastructure Solutions Group, Lenovo India at Lenovo Tech World’22, India edition on March 15th 2022, as we discuss the future of healthcare in India
https://t.co/JpfEk3Owgw
#Lenovo#TechWorldIndia22
Just published @Nature
Why do children usually have a mild Covid course?
A comprehensive assessment of innate and adaptive immunity, blood and airway epithelium. in kids and adults, shows there are multiple explanations https://t.co/M6iBoZZjtc
We'd all like to be an "elite neutralizer" of #SARSCoV2 🦠 but only rare people make ultrapotent antibodies, which can be the basis for making a pancoronavirus vaccine. A new bNAb discovery here active vs all variants assessed
https://t.co/Bv0Pc3Dyqj New @cellhostmicrobe
Need volunteers for a clinical trial. People with 2 doses of Covaxin 3-6 months ago are eligible to enroll in a booster dosing study. Folks in Vellore, Chennai, Bangalore or Delhi willing to consider participating please email [email protected]. Please retweet-thank you
1/n A weekend morning to gather my thoughts about Omicron and summarise what I think we know so far. Sharing it on Twitter is basically asking you all to correct me, so feel free to jump in, with any views within the frameworks of civil discussion.
A picture is worth a thousand words they say. So, here is the figure from the @sigallab preprint that worries me - consistent decline ~40x and basically only people with very high neutralization of ancestral, due to hybrid immunity, show effective activity against Omicron
"Omicron variant is the most highly mutated version of the SARS-CoV virus to date, with 30 amino acid changes, three small deletions and one small insertion in the spike protein," CSIR-IGIB director @AnuragAgrawalMD said.
@IGIBSocial@SumiSukanya https://t.co/uO0PlUryAF
From an multi-disciplinary, inter-institutional team, we present to you an independent, real world effectiveness, humoral and cellular immune responses post COVISHIELD vaccine during delta surge in India. https://t.co/3fNQYWZUAh
Extremely delighted to be a part of panel discussion on ‘Reproducibility’. It is essential especially for #AI driven applications in #healthcare for their wide spread validation and usage.
Join our workshop to participate in more interesting discussions on #AI